The results of in vitro and in vivo experiments showed that the expression of YRDC was positively associated with the proliferation and metastasis of HCC cells, and the mechanism exploration demonstrated that YRDC probably activates the MEK/ERK signaling pathway (Huang et al., 2019). Here, MAP2K7 is linked to hepatocellular carcinoma.